Swiss TPH Researcher Emma Hodcroft Named by Nature as 1 of 3 People To Watch in 2025 (News)
https://www.swisstph.ch/en/news/news-detail/news/swiss-tph-researcher-emma-hodcroft-named-by-nature-as-1-of-3-people-to-watch-in-2025
Emma Hodcroft, group leader at Swiss TPH and assistant professor at the University of Basel, has been named one of three people to watch in shaping science in 2025 by the prestigious journal Nature .
ANTICOV: Clinical Trial for COVID-19 in Low-resource Settings to Test a New Drug Combination (News)
https://www.swisstph.ch/en/news/news-detail/news/anticov-clinical-trial-for-covid-19-in-low-resource-settings-to-test-a-new-drug-combination
The ANTICOV trial, currently conducted in 13 African countries and soon expanding to additional countries in South Asia and Latin America, aims to identify COVID-19 treatments that are optimized for u
EMA Recommends Arpraziquantel for Treatment of Schistosomiasis in Preschool-Aged Children (News)
https://www.swisstph.ch/en/news/news-detail/news/ema-recommends-arpraziquantel-for-treatment-of-schistosomiasis-in-preschool-aged-children
Today, the Pediatric Praziquantel Consortium announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive scientific opinion for a
Swiss TPH Symposium: Women and Gender in Global Health (News)
https://www.swisstph.ch/en/news/news-detail/news/swiss-tph-symposium-women-and-gender-in-global-health
Women worldwide face unequal conditions when it comes to their health. On the one hand, socio-cultural factors, such as unequal power relations between men and women, uneven educational and financial
R. Geigy Award 2024: Cutting-Edge Research to Control Communicable and Non-Communicable Diseases in Côte D’Ivoire (News)
https://www.swisstph.ch/en/news/news-detail/news/r-geigy-award-2024-cutting-edge-research-to-control-communicable-and-non-communicable-diseases-in-cote-divoire
This year, the prestigious R. Geigy Award is presented to two research groups at the Centre Suisse de Recherches Scientifiques en Côte d’Ivoire (CSRS): epidemiologist and health economist Siaka Koné i
Children Not Less Active During COVID 19 Pandemic (News)
https://www.swisstph.ch/en/news/news-detail/news/children-not-less-active-during-covid-19-pandemic
SOPHYA ( S wiss Children's O bjectively Measured Phy sical A ctivity) is the first Swiss-wide long-term study that objectively measured the physical activity behaviour of children and adolescents. It
New Intervention Significantly Improved Mental Health Well-Being for Zambian Mothers (News)
https://www.swisstph.ch/en/news/news-detail/news/new-intervention-significantly-improved-mental-health-well-being-for-zambian-mothers
Mental health disorders, such as depression and anxiety, are becoming a growing challenge to global health, with women and low-income households being particularly affected. A previous study by Swiss
Children Will Experience Four Times More Extreme Events Due to Climate Change (News)
https://www.swisstph.ch/en/news/news-detail/news/children-will-experience-four-times-more-extreme-events-due-to-climate-change
Children and adolescents are especially vulnerable to climate change due to their developing bodies and immune systems. Extreme heat affects them more severely, making them more susceptible to dehydra
New Study Links Climate Change to Malaria Increase in Northern Kenya (News)
https://www.swisstph.ch/en/news/news-detail/news/new-study-links-climate-change-to-malaria-increase-in-northern-kenya
Malaria, spread by Anopheles mosquitoes, is one of the deadliest diseases in the world. In Kenya, malaria remains a major health challenge, particularly for children under the age of five years. With
Promising Genotyping Technique for Assessing Antimalarial Drug Efficacy (News)
https://www.swisstph.ch/en/news/news-detail/news/promising-genotyping-technique-for-assessing-antimalarial-drug-efficacy
Malaria remains a major global health concern, with 249 million cases and 608,000 deaths reported in 2022. Artemisinin-based combination therapies (ACTs) are currently one of the main strategies in th
